ContractCollaboration and License Agreement • March 21st, 2021
Contract Type FiledMarch 21st, 2021Relief and Acer Therapeutics Sign Collaboration and License Agreement for Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease